Our Pain Trials
Looking for participants aged 18-70 years old that have suffered gout for more than 2 years to help investigate the use of the Investigational Product, a local, topically administered NSAID. The goal of topical administration within this study is that by targeting treatment to only the area of flare-up, the inflammation and pain of a gout flare can both be treated, while potentially reducing the systemic side effects of oral NSAIDs.
This study is only being conducted at our Central Coast site.
Apply NowThis is a randomised, double-blind, placebo-controlled Phase 3 registration parallel arm study to evaluate the efficacy, safety and tolerability of 60 mg Promethean Health CBD daily vs. placebo in adults experiencing mild-to-moderate pain.
This study is being conducted at our Western Sydney, Canberra, Central Coast and Brisbane sites.
Apply NowParatus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326